John C. Pepia - Oct 29, 2021 Form 4 Insider Report for MEDNAX, INC. (MD)

Role
Principal Accounting Officer
Signature
/s/ Dominic J. Andreano, Attorney-in-Fact
Stock symbol
MD
Transactions as of
Oct 29, 2021
Transactions value $
-$248,225
Form type
4
Date filed
10/29/2021, 04:46 PM
Previous filing
Sep 3, 2021
Next filing
Nov 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MD Common Stock Sale -$248K -9.24K -8.33% $26.87 102K Oct 29, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $26.83 to $26.94 for a weighted average sales price of $26.87. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 Includes 61 shares acquired by the reporting person through the Issuer's Employee Stock Purchase Plan since the last Form 4 filing.